Literature DB >> 19925762

[Use of alfuzosin for expulsion of stones in the distal third of ureter].

Alejandro García Morúa1, Jesús Domingo Gutiérrez García, Rafael Martínez Montelongo, Lauro Salvador Gómez Guerra.   

Abstract

INTRODUCTION: Ureteral stones occur in approximately 12% of the population worldwide, and their incidence has significantly increased in recent years in Western countries. Seventy percent of ureteral stones are located in the distal third of the ureter. Several factors have a strong influence on spontaneous passage of ureteral stones, including stone size, shape, and location. Alpha blockers are currently attributed a potential role in rapid expulsion of stones in the distal third of the ureter.
MATERIALS AND METHODS: Thirty patients diagnosed of stones in the distal third of ureter of sizes ranging from 4 mm and 10 mm were divided into two groups. The first group was given Buscopan 10 mg plus ketorolac 10 mg every 8 hours, while the second group received alfuzosin 10 mg every 24 hours.
RESULTS: In group 1, mean stone size was 6.4 mm. Stone expulsion occurred in only 4 patients after a mean of 11.4 days. In group 2, mean stone size was 5.8 mm, and stone expulsion occurred in 13 patients after a mean of 3.3 days.The two stones that were not passed where the biggest ones (9 mm and 10 mm).
CONCLUSIONS: Use of alpha-adrenergic blockers for ureteral distal third stones has been shown to be effective for increasing the stone expulsion rate and even the number of stones passed, and for faster symptom relief. Copyright 2009 AEU. Published by Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925762     DOI: 10.1016/s0210-4806(09)72901-8

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  5 in total

1.  Inflammatory serum markers predicting spontaneous ureteral stone passage.

Authors:  Nassib Abou Heidar; Muhieddine Labban; Gerges Bustros; Rami Nasr
Journal:  Clin Exp Nephrol       Date:  2019-11-08       Impact factor: 2.801

2.  2,2-Bis(hy-droxy-meth-yl)-2,3-dihydro-1H-pyrrolizin-1-one.

Authors:  Yousuf Ali; Yu Peng; Erbing Hua; Nighat Afza; Rashid Ali Khan
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-05

3.  {2-[(Benzo-yloxy)meth-yl]-1-oxo-3H-pyrrolizin-2-yl}methyl benzoate.

Authors:  Yousaf Ali; Sammer Yousuf; Nighat Afza; Yu Peng; Mahboob Ali Kalhoro
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-18

4.  The role of inflammatory serum markers and ureteral wall thickness on spontaneous passage of ureteral stone < 10 mm: A prospective cohort study.

Authors:  Ismaeel Aghaways; Rebaz Ibrahim; Rawa Bapir; Rawezh Q Salih; Karzan M Salih; Berwn A Abdulla
Journal:  Ann Med Surg (Lond)       Date:  2022-07-16

Review 5.  Efficacy and Safety of Alfuzosin as Medical Expulsive Therapy for Ureteral Stones: A Systematic Review and Meta-Analysis.

Authors:  Chenli Liu; Guohua Zeng; Ran Kang; Wenqi Wu; Jiasheng Li; Kang Chen; Show P Wan
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.